2m 2m 2m 2m 2m 2m 2m
NovoCure NPV (NVCR)
NASDAQ
$14.06-$0.08 (-0.53%)
Price as of Jun 23, 2026 7:23 PM EDT- $1.5BMarket Cap
- -18.06%1-Year Change
- Medical DevicesIndustry
NovoCure NPV (NVCR)
$14.06-$0.08 (-0.53%)
NVCR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $14.13 | ||
Change | -$0.67 (-4.69%) | ||
Open | $13.43 | ||
High | $14.31 | ||
Low | $13.43 | ||
Previous Close | $13.61 | ||
Volume | 1,752,294 | ||
30-Day Average Volume | 1,740,276 | ||
1-Week Change | -22.67% | ||
1-Month Change | -24.22% | ||
1-Year Change | -18.06% | ||
3-Year Change | -69.32% | ||
5-Year Change | -93.94% | ||
Fundamentals | |||
Shares Outstanding | 111.5M | ||
Total Assets | $787.9M | ||
Market Cap | $1.5B | ||
Enterprise Value | $1.6B | ||
Period: QTR TTM FY | |||
Revenue | $174.1M | ||
Net Income | -$71.1M | ||
Free Cash Flow | -$18.7M | ||
EBIT | -$67.4M | ||
EBITDA | -$63.3M | ||
Net Working Capital | $414.1M | ||
EPS | -$0.62 | ||
Enterprise Value/EBITDA | -26 | ||
Enterprise Value/Revenue | 9 | ||
P/B | 5 | ||
P/E | -22 | ||
PEG | 0 | ||
Price/Free Cash Flow | -81 | ||
Price/Operating Cash Flow | -112 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue